iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Peapack Gladstone Financial Corp

Peapack Gladstone Financial Corp lowered its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 4.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 66,511 shares of the financial services provider’s stock after selling 2,951 shares during the quarter. Peapack Gladstone Financial Corp owned about 0.13% of iShares Biotechnology ETF worth $9,683,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in IBB. Darwin Wealth Management LLC acquired a new position in iShares Biotechnology ETF in the 3rd quarter valued at $29,000. Highline Wealth Partners LLC purchased a new stake in shares of iShares Biotechnology ETF in the third quarter valued at about $30,000. Ashton Thomas Securities LLC acquired a new position in shares of iShares Biotechnology ETF during the third quarter worth about $36,000. Voisard Asset Management Group Inc. purchased a new position in iShares Biotechnology ETF during the third quarter worth about $59,000. Finally, Aptus Capital Advisors LLC lifted its position in iShares Biotechnology ETF by 36.5% in the third quarter. Aptus Capital Advisors LLC now owns 426 shares of the financial services provider’s stock valued at $62,000 after purchasing an additional 114 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.8 %

Shares of IBB opened at $136.61 on Friday. The stock’s 50 day moving average is $141.84 and its two-hundred day moving average is $142.25. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57.

iShares Biotechnology ETF Announces Dividend

The firm also recently disclosed a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.